Parry Renate
Gyre Therapeutics, Inc. · Director
Parry Renate is listed in filings as Director at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 6, 2025, including 2 public disclosures. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Aug 16, 2024 to Jun 6, 2025. Reported amounts are shown as $519.0K to $223.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||